T he implantation of stents in coronary arteries or saphenous vein bypass grafts as an adjunct or alternative to percutaneous transluminal coronary angioplasty (PTCA) was initially proposed to prevent late restenosis.' Since March 1986, the coronary Wallstent® has been the most intensively studied endovascular prosthesis in Europe. As a result of cooperation among the six participating European centers, a central core laboratory was set up in Rotterdam to objectively assess the follow-up of stents with quantitative coronary angiography. In our previous report on the initial 117 stents implanted in 105 patients, we observed that late angiographic narrowing occurs in a significant number of patients.2 To further characterize the factors associated with angiographic restenosis within the stented segment, we retrospectively studied and March 1990 at the six participating centers. The study group consisted of 222 men and 43 women with a mean age of 58±+11 years. Sixty-two percent of the stents were implanted in native vessels, and 38% were placed in bypass grafts. In the overall group, angiographic follow-up was obtained in 218 patients (82%). However, in-hospital occlusions (40 patients, 41 lesions) were excluded from this study since these were definite thrombotic events and the objective of this study was late angiographic narrowing. Follow-up angiograms were quantitatively analyzed in 176 patients (78%) of the 225 patients who were discharged from hospital without known occlusion (Figures 1 and 2 (Tables 1 and 2 ). These particular variables were of a priori clinical interest on the basis of previously published PTCA and stent reports.5-11
Statistical Methods
A relative risk analysis was performed for the aforementioned discrete and continuous variables.'2 The continuous variables were dichotomized for the risk ratio analysis. To avoid arbitrary subdivision of data in continuous variables, cutpoints were derived by dividing the data into two groups, each containing roughly 50% of the total population. This method of subdivision has the advantage of being consistent for all variables and thus avoids any bias in selection of subgroups that might be undertaken to emphasize a particular point. The incidence of restenosis in the two groups was compared using a relative risk analy- (see below). We believe that this is due to a more uniform and optimal dilatation with stenting. Long lesions treated with angioplasty are frequently less successfully dilated along the entire length of the lesion and the ragged irregular surface of the vessel may predispose to rheological factors critically involved in restenosis. Total occlusions have been reported as an important predictor of restenosis in angioplasty studies. However, this accounted for only 4.5% of the lesions in our study, which was too few for this analysis. Although there was a trend for higher restenosis in more eccentric lesions, this was not statistically significant. The vessel is subjected to increasingly higher wall stress than after implantation of a balloon expandable stent (which is maximally expanded at the time of implantation), a factor which may adversely stimulate the proliferative process. It may seem paradoxical that oversizing the stent by more than 0.7 mm would result in a higher restenosis rate with the 50% DS criterion. However, the diameter stenosis after stent was not different in the two groups despite the oversizing. The main effect of oversizing then was not particularly a superior immediate result but rather a more aggressive "hyperplastic" reaction and a smaller MLD at follow-up than if less oversized stents were implanted. The absolute value of the unconstrained stent diameter and the addition of the polymer coating (Biogold®) had no significant relation to late restenosis.
Procedural Factors
No significant relative risk could be attributed to a particular indication for the procedure. Restenosis rates for primary cases were not significantly different than for bail-out or restenosis cases (MLD criterion: 37%, 42%, 33%; DS criterion: 24%, 27%, 24%), although an increased rate of restenosis has been described with the Palmaz-Schatz stent in patients with previous restenosis. 30 The absolute change in diameter from the prestent to the poststent result and dilatation within the stent after implantation (the so-called "Swiss Kiss") did not appear to affect the late restenosis. This poststent dilatation was performed to dissipate a clot within the stent and to accelerate early expansion of the stent. A post stent diameter stenosis more than 20% tended to be predictive of a follow-up diameter stenosis more than 50% (RR, 1.51; 95% CI, 0.91-2.50) although not for the MLD criteria. The larger the residual stenosis following stenting (i.e., less optimal result), the less hyperplasia is required to reach a particular diameter stenosis at follow-up such as the 50% diameter stenosis criterion.
Limitations of Study
Several important limitations of this study must be mentioned. Although this study suggests several factors that may be predictive of restenosis following stenting, it does not address the actual mechanisms of restenosis in the stented vessel. By comparing the predictors of restenosis following stenting to angioplasty, we have assumed that the underlying mechanism(s) responsible for late angiographic narrowing are similar (i.e., primarily intimal hyperplasia). Although almost every stenting procedure was accompanied by balloon dilatation at some particular time during the procedure, several other mechanisms may be important. Elastic recoil, which in the first few days following the procedure may be a significant factor in causing renarrowing, may be less imfportant in stented vessels than angioplasty alone due to the scaffolding function of the stent. Although organization of thrombus at the site of intimal damage following PTCA has been recognized as a cause for late restenosis, it has not been particularly regarded as an important factor based on late pathological studies following PTCA. However, this may be an extremely important cause of late restenosis after stenting. Although it is difficult to histologically discriminate thrombus organization from intimal hyperplasia, we have observed a disorganized layer of intimal thickening directly above the stent wire associated with remnants of thrombus in segments of several bypass grafts that have been surgically re- trieved up to 10 months following stent implantation ( Figure 4) .33,34 Therefore, we consider organization of residual thrombus to be a potentially important cause of late angiographic narrowing in addition to the major occlusion problems early after stenting. This may partially explain why commonly regarded determinants of restenosis following PTCA (e.g., lesion length, LAD) do not appear to be significant in this analysis because different pathological processes may predominate. This also has important clinical implications since therapy to limit smooth muscle proliferation may be quite different than therapy to minimize thrombus formation. There are two statistical limitations to this study. Due to the relatively small sample size, we cannot rule out a significant beta error. Second, in performing multiple statistical comparisons, there is a risk that some of them may be significant by chance alone. Therefore, this data requires confirmation by other studies.
In conclusion, the European coronary Wallstent® experience has demonstrated that restenosis following stenting is increased in bypass grafts and in the presence of multiple stents and excessive oversizing of the stent (>0.7 mm) and less optimal results immediately post stenting (>20% diameter stenosis). Since some of these factors can be modified, we recommend against the use of multiple stents and excessive oversizing to reduce the probability of late restenosis.
